EMDR has been credited for helping stars like PrinceHarry and MileyCyrus heal their trauma. Here, an expert answers all our questions on EMDR, from how it works to who it is suitable for.
The short answer is yes. Anxiety is a symptom of many conditions successfully treated by EMDR, like phobias, panic disorder, social anxiety, PTSD, complex PTSD and attachment trauma. By targeting the memories they are linked to, EMDR can “neutralise these events and reduce the anxiety”, says Oakley.“We talk about ‘big T’ traumas and ‘small t’ traumas,” says Oakley.
”According to Oakley, some mental health professionals do not yet fully understand what makes it work. But, she adds: “Its efficacy in treating trauma has been proven in more than 40 clinical randomised trials and it is recommended by leading organisations like the World Health Organisation and theWhile there is limited research to suggest self-administered EMDR can be beneficial in some cases, because it is a “power tool”, the majority of experienced clinicians do not recommend it.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Could phage therapy help combat antimicrobial resistance?Our podcast on science and technology. This week, we explore the potential of bacteriophages—viruses that can destroy superbugs—and why their time might have come
Read more »
Stiffness and axial pain are associated with the progression of calcification in a mouse model of diffuse idiopathic skeletal hyperostosis - Arthritis Research & TherapyBackground Diffuse idiopathic skeletal hyperostosis (DISH) is characterized by progressive calcification of spinal tissues; however, the impact of calcification on pain and function is poorly understood. This study examined the association between progressive ectopic spine calcification in mice lacking equilibrative nucleoside transporter 1 (ENT1−/−), a preclinical model of DISH, and behavioral indicators of pain. Methods A longitudinal study design was used to assess radiating pain, axial discomfort, and physical function in wild-type and ENT1−/− mice at 2, 4, and 6 months. At endpoint, spinal cords were isolated for immunohistochemical analysis of astrocytes (GFAP), microglia (IBA1), and nociceptive innervation (CGRP). Results Increased spine calcification in ENT1−/− mice was associated with reductions in flexmaze exploration, vertical activity in an open field, and self-supporting behavior in tail suspension, suggesting flexion-induced discomfort or stiffness. Grip force during the axial stretch was also reduced in ENT1−/− mice at 6 months of age. Increased CGRP immunoreactivity was detected in the spinal cords of female and male ENT1−/− mice compared to wild-type. GFAP- and IBA1-immunoreactivity were increased in female ENT1−/− mice compared to wild-type, suggesting an increase in nociceptive innervation. Conclusion These data suggest that ENT1−/− mice experience axial discomfort and/or stiffness and importantly that these features are detected during the early stages of spine calcification.
Read more »
The Interplay among Glucocorticoid Therapy, Platelet-Activating Factor and Endocannabinoid Release Influences the Inflammatory Response to COVID-19COVID-19 is associated with a dysregulated immune response. Currently, several medicines are licensed for the treatment of this disease. Due to their significant role in inhibiting pro-inflammatory cytokines and lipid mediators, glucocorticoids (GCs) have attracted a great deal of attention. Similarly, the endocannabinoid (eCB) system regulates various physiological processes including the immunological response. Additionally, during inflammatory and thrombotic processes, phospholipids from cell membranes are cleaved to produce platelet-activating factor (PAF), another lipid mediator. Nonetheless, the effect of GCs on this lipid pathway during COVID-19 therapy is still unknown. This is a cross-sectional study involving COVID-19 patients (n=200) and healthy controls (n=35). Target tandem mass spectrometry of plasma lipid mediators demonstrated that COVID-19 severity affected eCBs and PAF synthesis. This increased synthesis of eCB was adversely linked with systemic inflammatory markers IL-6 and sTREM-1 levels and neutrophil counts. The use of GCs altered these lipid pathways by reducing PAF and increasing 2-AG production. Corroborating this, transcriptome analysis of GC-treated patients blood leukocytes showed differential modulation of monoacylglycerol lipase and phospholipase A2 gene expression. Altogether, these findings offer a breakthrough in our understanding of COVID-19 pathophysiology, indicating that GCs may promote additional protective pharmacological effects by influencing the eCB and PAF pathways involved in the disease course.
Read more »
Essential service for kids with home adaption needs now under council controlBlackburn with Darwen's Paediatric Occupational Therapy for Disabled Facilities Grant and Education Service is now back in council hands
Read more »